9.01.2004
GPC Biotech Begins Satraplatin Study To Treat Lung Cancer
GPC Biotech Begins Satraplatin Study To Treat Lung Cancer
a Phase 1/ 2 study to evaluate the combination of its lead drug candidate satraplatin and simultaneous radiation therapy in patients with locally advanced non-small cell lung cancer (NSCLC) has opened for accrual. The study is an open label, single center study being led by Hak Choy, M.D., Professor and Chair of the Department of Radiation Oncology at the University of Texas Southwestern Medical Center at Dallas.
news.morningstar.com - Sep 1 2004 15:48:16 GMT
[All Headline News - News and Headlines]
a Phase 1/ 2 study to evaluate the combination of its lead drug candidate satraplatin and simultaneous radiation therapy in patients with locally advanced non-small cell lung cancer (NSCLC) has opened for accrual. The study is an open label, single center study being led by Hak Choy, M.D., Professor and Chair of the Department of Radiation Oncology at the University of Texas Southwestern Medical Center at Dallas.
news.morningstar.com - Sep 1 2004 15:48:16 GMT
[All Headline News - News and Headlines]
Study reveals first genetic step necessary for prostate cancer growth
Study reveals first genetic step necessary for prostate cancer growth
A new study from Fred Hutchinson Cancer Research Center reveals what may be the earliest step in the development of prostate cancer. The finding could open the door to new tests that predict whether the cancer will become aggressive and the development of treatments to prevent the condition from progressing.
[feedsfarm.com Search: cancer]
Sept. 1 issue of Cancer Researc
A new study from Fred Hutchinson Cancer Research Center reveals what may be the earliest step in the development of prostate cancer. The finding could open the door to new tests that predict whether the cancer will become aggressive and the development of treatments to prevent the condition from progressing.
[feedsfarm.com Search: cancer]
Sept. 1 issue of Cancer Researc
8.31.2004
Mammography Cuts Risk of Cancer Recurrence -- Study
Mammography Cuts Risk of Cancer Recurrence -- Study
CHICAGO (Reuters) - Women whose breast cancer is detected by mammography have a lower risk of the cancer recurring after treatment compared to those who discover a tumor by other means, a Finnish study said on Tuesday.
[Reuters: Health]
Journal of the American Medical Association
CHICAGO (Reuters) - Women whose breast cancer is detected by mammography have a lower risk of the cancer recurring after treatment compared to those who discover a tumor by other means, a Finnish study said on Tuesday.
[Reuters: Health]
Journal of the American Medical Association
Anti cancer compound in vegetables blocks late stage breast cancer cell growth
Anti cancer compound in vegetables blocks late stage breast cancer cell growth
A well-known anti-cancer agent in certain vegetables has just had its reputation enhanced. The compound, in broccoli and other cruciferous vegetables, has been found to be effective in disrupting late stages of cell growth in breast cancer.
medicalnewstoday.com - Sep 1 2004 4:19:13 GMT
[All Headline News - News and Headlines]
September issue of the Journal of Nutrition
A well-known anti-cancer agent in certain vegetables has just had its reputation enhanced. The compound, in broccoli and other cruciferous vegetables, has been found to be effective in disrupting late stages of cell growth in breast cancer.
medicalnewstoday.com - Sep 1 2004 4:19:13 GMT
[All Headline News - News and Headlines]
September issue of the Journal of Nutrition
Cancer Survivors Have Poorer Quality of Life
Cancer Survivors Have Poorer Quality of Life
For cancer survivors, physical and emotional problems continue long after treatment ends.
[Cancer - Topix.net]
Journal of the National Cancer Institute.
For cancer survivors, physical and emotional problems continue long after treatment ends.
[Cancer - Topix.net]
Journal of the National Cancer Institute.
Green tea research leads to gum and other products
Green tea research leads to gum and other products
The health benefits of green tea are finding their way into gum, mints, skin cream and other products with the help of a Medical College of Georgia cell biologist.
[Cancer - Topix.net]
The health benefits of green tea are finding their way into gum, mints, skin cream and other products with the help of a Medical College of Georgia cell biologist.
[Cancer - Topix.net]
Study Shows Colonoscopy Misses 4% of Cancers
Study Shows Colonoscopy Misses 4% of Cancers
Colonoscopy is currently considered the best way to screen for and detect colon cancer, which is the second leading cause of cancer-related deaths in the U.S. and Canada. Four percent of cancers on the right-hand side of the colon are not detected by colonoscopy, according to a Canadian study published in the journal Gastroenterology.
[feedsfarm.com Search: cancer]
Colonoscopy is currently considered the best way to screen for and detect colon cancer, which is the second leading cause of cancer-related deaths in the U.S. and Canada. Four percent of cancers on the right-hand side of the colon are not detected by colonoscopy, according to a Canadian study published in the journal Gastroenterology.
[feedsfarm.com Search: cancer]
Facing the Mirror with Cancer
Facing the Mirror with Cancer
While the link between a positive attitude and recovery has gained acceptance with physicians and cancer patients alike, the biggest hurdle in achieving that attitude presents itself for those with cancer every ... In her new FACING THE MIRROR WITH CANCER: A Guide to Using Makeup to Make a Difference (Belle Press) Ovitz addresses the heavy toll that side effects can take on the millions of patients struggling through debilitating treatments such as chemotherapy, invasive medical procedures and surgeries.
[Cancer - Topix.net]
While the link between a positive attitude and recovery has gained acceptance with physicians and cancer patients alike, the biggest hurdle in achieving that attitude presents itself for those with cancer every ... In her new FACING THE MIRROR WITH CANCER: A Guide to Using Makeup to Make a Difference (Belle Press) Ovitz addresses the heavy toll that side effects can take on the millions of patients struggling through debilitating treatments such as chemotherapy, invasive medical procedures and surgeries.
[Cancer - Topix.net]
Study stirs debate over full-body scans' cancer risk
Study stirs debate over full-body scans' cancer risk
People who have full-body CT screenings to detect potential health problems are exposed to about as much radiation as some survivors of the Hiroshima and Nagasaki atomic bombings, a study in Tuesday's journal Radiology reports.
news.yahoo.com - Aug 31 2004 15:26:1 GMT
[All Headline News - News and Headlines]
People who have full-body CT screenings to detect potential health problems are exposed to about as much radiation as some survivors of the Hiroshima and Nagasaki atomic bombings, a study in Tuesday's journal Radiology reports.
news.yahoo.com - Aug 31 2004 15:26:1 GMT
[All Headline News - News and Headlines]
8.30.2004
Funding sought for radio wave cancer therapy
FollowUPFunding sought for radio wave cancer therapy
Sen. Arlen Specter is working to put a Washington County native's experimental cancer treatment on the funding fast track so animal testing can begin at the University of Pittsburgh Medical Center.
post-gazette.com - Aug 30 2004 9:30:11 GMT
[All Headline News - News and Headlines]
Sen. Arlen Specter is working to put a Washington County native's experimental cancer treatment on the funding fast track so animal testing can begin at the University of Pittsburgh Medical Center.
post-gazette.com - Aug 30 2004 9:30:11 GMT
[All Headline News - News and Headlines]
Cinical trial to evaluate breakthrough breast cancer treatment
Cinical trial to evaluate breakthrough breast cancer treatment
news-medical.net - Aug 31 2004 5:20:30 GMT
Virginia Commonwealth University’s Massey Cancer Center will host 20 medical experts from around the United States on Sept. 9 to prepare for a 3,000-patient phase III clinical trial that will evaluate a breakthrough breast cancer treatment.
The radiation oncologists, surgeons, a physicist and other experts will explore their early findings of patient outcomes with MammoSite RTS, a relatively new radiation delivery technology that dramatically reduces the entire radiation treatment process for patients who have had lumpectomies to remove breast tumors.
[All Headline News - News and Headlines]
news-medical.net - Aug 31 2004 5:20:30 GMT
Virginia Commonwealth University’s Massey Cancer Center will host 20 medical experts from around the United States on Sept. 9 to prepare for a 3,000-patient phase III clinical trial that will evaluate a breakthrough breast cancer treatment.
The radiation oncologists, surgeons, a physicist and other experts will explore their early findings of patient outcomes with MammoSite RTS, a relatively new radiation delivery technology that dramatically reduces the entire radiation treatment process for patients who have had lumpectomies to remove breast tumors.
[All Headline News - News and Headlines]
NIH Fact Sheet for Public Access Publishing
NIH Fact Sheet for Public Access Publishing
The NIH has prepared a Fact Sheet on Public Access Publishing that it sent to participants in today's invitation-only stakeholder meeting on the open-access plan. Excerpt: "The goals of the agency specifically include expanding the knowledge base in medical and associated sciences, in order to enhance the Nation's well-being and ensure a continued high return on the public investment in research. The sharing of ideas, data, and research findings has always been encouraged by NIH as a primary mechanism for accomplishing these objectives....NIH is aware of many of the implications of possible changes to the current publishing model. As the agency works towards the development of a policy statement on public access publishing, two important goals must be considered: first, the need to give the public taxpayers who support NIH research better access to the results of its investment; and second, the need for NIH to have a full compendium of research results including clinical trials outcomes that it can use to manage its research portfolio and monitor scientific productivity. An additional consideration is the need to preserve the ability of journals and publishers to play a major role in peer review and to facilitate information transfer. As part of on-going efforts to gather input on this issue, NIH Director Dr. Elias A. Zerhouni is holding a series of meetings to consider the concerns of affected parties including publishers, scientists, and patient advocates. The NIH Guide for Grants and Contracts will publish a draft policy statement in September for public comment. This draft policy will take into account the input that NIH receives on this issue, and present a clear description of the agency's position and planned actions in the area of public access. In December, NIH will report to Congress on its consultations and proposed next steps."
[Open Access News]
The NIH has prepared a Fact Sheet on Public Access Publishing that it sent to participants in today's invitation-only stakeholder meeting on the open-access plan. Excerpt: "The goals of the agency specifically include expanding the knowledge base in medical and associated sciences, in order to enhance the Nation's well-being and ensure a continued high return on the public investment in research. The sharing of ideas, data, and research findings has always been encouraged by NIH as a primary mechanism for accomplishing these objectives....NIH is aware of many of the implications of possible changes to the current publishing model. As the agency works towards the development of a policy statement on public access publishing, two important goals must be considered: first, the need to give the public taxpayers who support NIH research better access to the results of its investment; and second, the need for NIH to have a full compendium of research results including clinical trials outcomes that it can use to manage its research portfolio and monitor scientific productivity. An additional consideration is the need to preserve the ability of journals and publishers to play a major role in peer review and to facilitate information transfer. As part of on-going efforts to gather input on this issue, NIH Director Dr. Elias A. Zerhouni is holding a series of meetings to consider the concerns of affected parties including publishers, scientists, and patient advocates. The NIH Guide for Grants and Contracts will publish a draft policy statement in September for public comment. This draft policy will take into account the input that NIH receives on this issue, and present a clear description of the agency's position and planned actions in the area of public access. In December, NIH will report to Congress on its consultations and proposed next steps."
[Open Access News]
Probing the Surface of White Blood Cells to Enhance Immune System Medicine
Probing the Surface of White Blood Cells to Enhance Immune System Medicine
White blood cells are the principle mediators of immune system function, yet efforts to influence their role in illness have been hampered due to a lack of understanding of the surface structure of these cells - until now... click link for more info. Dartmouth Medical School researchers characterize the structure of white blood cells and challenge assumptions about how a certain immunodeficiency disorder affects the white blood cell surface in the September 1 issue of Blood,
[Medical News Today]
White blood cells are the principle mediators of immune system function, yet efforts to influence their role in illness have been hampered due to a lack of understanding of the surface structure of these cells - until now... click link for more info. Dartmouth Medical School researchers characterize the structure of white blood cells and challenge assumptions about how a certain immunodeficiency disorder affects the white blood cell surface in the September 1 issue of Blood,
[Medical News Today]
Yin Yang of Ginseng, need for stronger regulations of herbal drugs
Yin Yang of Ginseng, need for stronger regulations of herbal drugs
In work that emphasizes the need for stronger regulations of herbal drugs, an international team of MIT scientists and colleagues has unraveled the yin and the yang of ginseng, or why the popular alternative medicine can have two entirely different, opposing effects on the body... click link for more info.
[Medical News Today]
Sept. 7, 2004 issue of Circulation
In work that emphasizes the need for stronger regulations of herbal drugs, an international team of MIT scientists and colleagues has unraveled the yin and the yang of ginseng, or why the popular alternative medicine can have two entirely different, opposing effects on the body... click link for more info.
[Medical News Today]
Sept. 7, 2004 issue of Circulation
Cancer Drug Still an Option for Allergic Patients
Cancer Drug Still an Option for Allergic Patients
NEW YORK (Reuters Health) - Carboplatin, a drug used to treat ovarian and other cancers, can be given to allergic patients provided that they are slowly desensitized to the drug. This is important for doctors to remember since carboplatin is an effective drug, but up to 30 percent of patients treated it will develop an allergy.
[Reuters: Health]
NEW YORK (Reuters Health) - Carboplatin, a drug used to treat ovarian and other cancers, can be given to allergic patients provided that they are slowly desensitized to the drug. This is important for doctors to remember since carboplatin is an effective drug, but up to 30 percent of patients treated it will develop an allergy.
[Reuters: Health]
MedlinePlus: Understanding Medical Research
MedlinePlus: Understanding Medical Research
A *NEW* website with information and links on the topic of Understanding Medical Research....
[UMN: Bio-Med Library - Public Health]
A *NEW* website with information and links on the topic of Understanding Medical Research....
[UMN: Bio-Med Library - Public Health]
Obesity Linked to Worse Prostate Cancer Outcome
Obesity Linked to Worse Prostate Cancer Outcome
NEW YORK (Reuters Health) - Obese men who undergo surgery for prostate cancer are more likely than their non-obese peers to experience a rise in prostate-specific antigen (PSA) levels, a sign that their disease is returning, new research suggests. Moreover, this seems to be true even in cases in which all of the cancer was apparently removed at surgery.
[feedsfarm.com Search: cancer]
Journal of Urology
NEW YORK (Reuters Health) - Obese men who undergo surgery for prostate cancer are more likely than their non-obese peers to experience a rise in prostate-specific antigen (PSA) levels, a sign that their disease is returning, new research suggests. Moreover, this seems to be true even in cases in which all of the cancer was apparently removed at surgery.
[feedsfarm.com Search: cancer]
Journal of Urology
How an insidious mutation fools DNA replication
How an insidious mutation fools DNA replication
Biochemists have pinpointed how a flaw in DNA that is central to mutations in cancer and aging fools the cellular enzyme that copies DNA. Their finding explains how oxidative DNA damage -- a process long believed to underlie cancers and aging -- can create permanent genetic damage.
[feedsfarm.com Search: cancer]
Aug. 22, 2004, by the journal Nature
Biochemists have pinpointed how a flaw in DNA that is central to mutations in cancer and aging fools the cellular enzyme that copies DNA. Their finding explains how oxidative DNA damage -- a process long believed to underlie cancers and aging -- can create permanent genetic damage.
[feedsfarm.com Search: cancer]
Aug. 22, 2004, by the journal Nature
